Ipragliflozin
Ipragliflozin is a potent inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC₅₀ = 7.4 nM for human SGLT2 in vitro) that increases excretion of glucose.Iipragliflozin is found to promote preferential loss of fat mass in a rat model of non-obese type 2 diabetes mellitus (T2DM).
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx06815-1mgEcoli 1 mg (E. coli)
Recombinant Shigella Dysenteriae dadA Protein (aa 1-432)
Sign In for Pricing
View Details